171 related articles for article (PubMed ID: 573692)
1. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
Crawley JN; Laverty R; Roth RH
Eur J Pharmacol; 1979 Aug; 57(2-3):247-50. PubMed ID: 573692
[TBL] [Abstract][Full Text] [Related]
2. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
Roth RH; Elsworth JD; Redmond DE
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
4. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
Esposito E; Kruszewska A; Ossowska G; Samanin R
Psychopharmacology (Berl); 1987; 93(3):393-6. PubMed ID: 3124170
[TBL] [Abstract][Full Text] [Related]
6. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats.
Laverty R; Roth RH
Brain Res; 1980 Jan; 182(2):482-5. PubMed ID: 7188872
[No Abstract] [Full Text] [Related]
7. Comparison of two alpha-noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence.
Zigun JR; Bannon MJ; Roth RH
Eur J Pharmacol; 1981 Apr; 70(4):565-70. PubMed ID: 6113150
[TBL] [Abstract][Full Text] [Related]
8. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
9. Brain catecholamine metabolites and behavior in morphine withdrawal.
Swann AC; Elsworth JD; Charney DS; Jablons DM; Roth RH; Redmond DE; Maas JW
Eur J Pharmacol; 1982 Dec; 86(2):167-75. PubMed ID: 6297931
[TBL] [Abstract][Full Text] [Related]
10. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
[TBL] [Abstract][Full Text] [Related]
11. Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms.
Rossetti ZL; Longu G; Mercuro G; Gessa GL
Brain Res; 1993 Apr; 609(1-2):316-20. PubMed ID: 8508313
[TBL] [Abstract][Full Text] [Related]
12. Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain.
Galloway MP; Roth RH
J Neurochem; 1983 Jan; 40(1):246-51. PubMed ID: 6184449
[TBL] [Abstract][Full Text] [Related]
13. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
[TBL] [Abstract][Full Text] [Related]
14. Diazepam pretreatment suppresses morphine withdrawal signs in the mouse.
Suzuki T; Tsuda M; Narita M; Funada M; Mizoguchi H; Misawa M
Life Sci; 1996; 58(4):349-57. PubMed ID: 8538371
[TBL] [Abstract][Full Text] [Related]
15. Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo.
Done C; Silverstone P; Sharp T
Eur J Pharmacol; 1992 May; 215(2-3):333-6. PubMed ID: 1397000
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
Gonzalvez ML; Milanés MV; Martinez-Piñero MG; Marín MT; Vargas ML
Brain Res; 1994 Jun; 647(2):199-203. PubMed ID: 7922496
[TBL] [Abstract][Full Text] [Related]
17. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
Kamei J; Ohsawa M
Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.
Bongianni F; Carla V; Moroni F; Pellegrini-Giampietro DE
Br J Pharmacol; 1986 Jul; 88(3):561-7. PubMed ID: 3017487
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
20. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
Kimes AS; Bell JA; London ED
Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]